Since semaglutide is still under patent in South Africa and Novo Nordisk has not issued licences for other companies to import the peptide or make generic copies of it, all compounded GLP-1s containing this API are illegal, said Novo Nordisk South Africas Head of legal ethics, compliance and quality, Jonas Lind Hansen
Why choose a GLP-1 powder supplement over capsules or gummies
Key takeaways Ozempic and Jardiance are FDA approved to treat Type 2 diabetes but differ in mechanism of action, active ingredients, dosage forms, and side effects
Current Evidence and Availability in the UK Retatrutide remains an investigational compound with no MHRA or EMA marketing authorisation
In addition, compounded semaglutide is typically made by specialty pharmacies using raw ingredients sourced from suppliers
While GLP-1 medications can be administered at any time of day (consistent with prescribing information), some patients report personal preference for evening administration